Stoke Therapeutics, Inc. (STOK) Total liabilities 2022–2025
Stoke Therapeutics, Inc. (STOK) total liabilities at each fiscal year-end, per SEC filings.
$66.0MFY2025 · since FY2022: $71.2M → $66.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $66.0M | +55.1% |
| FY2024 | $42.5M | -38.2% |
| FY2023 | $68.8M | -3.4% |
| FY2022 | $71.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice